Future Directions of Marine Bacterial Natural Products
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (15 December 2021) | Viewed by 17798
Special Issue Editor
Interests: microorganisms; myxobacteria; microbial natural products; drug discovery; phylogeny; taxonomy; systematics; metagenomics; genomics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Marine- and estuarine-derived bacteria are continuously gaining attention as a source of novel bioactive compounds. Marine actinobacteria, gliding bacteria, and myxobacteria are well-known producers of diverse secondary metabolites. Many of these natural compounds are novel and often associated with new bacterial strains. Metagenomic studies in salt-containing habitats and host organisms such as sponges, corals, and seagrasses indicate the presence of complex bacterial communities. Moreover, some studies have linked these possible bacterial associations with marine host organisms to the parallel production of similar compounds, as in the cases of apicularen A and salicylihalamide A, bengamide E and F, chondromide A–D and jasplakinolide, microsclerodermin D, and saframycin Mx1 and renieramycin A. Although the cultivation of these microorganisms may be very challenging due to the unknown or poorly understood physiology, marine bacteria may still be worth investigating to discover novel compounds.
It is a great pleasure to invite authors to submit their original research or review articles to this Special Issue within the wide scope of marine bacteria, their natural products, and the future direction for marine drug discovery.
Dr. Ronald O. Garcia
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine- and estuarine-derived bacteria
- gliding marine bacteria
- marine myxobacteria
- marine actinobacteria
- bioactive compounds
- marine metagenomics and biodiversity
- marine natural products
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.